Short lung transplant donor telomere length is associated with decreased CLAD-free survival

Thorax

Volumn 72, Issue 11, 2017, Pages 1052-1054

  Faust, Hilary E ^a,b   Golden, Jeffrey A ^b   Rajalingam, Raja ^b   Wang, Angelia S ^b   Green, Gary ^b   Hays, Steven R ^b   Kukreja, Jasleen ^b   Singer, Jonathan P ^b   Wolters, Paul J ^b   Greenland, John R ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Lung Transplantation

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CHRONIC LUNG ALLOGRAFT DYSFUNCTION; CYTOPENIA; DISEASE ASSOCIATION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY RATE; ONSET AGE; ORGAN DONOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY EPITHELIUM; RISK ASSESSMENT; RISK FACTOR; TELOMERE LENGTH; ADULT; AGE; AGED; CALIFORNIA; COHORT ANALYSIS; FEMALE; GENETICS; LIVING DONOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; TELOMERE; TELOMERE SHORTENING; TREATMENT OUTCOME;

BIOLOGICAL MARKER;

ADULT; AGE FACTORS; AGED; BIOMARKERS; CALIFORNIA; COHORT STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVING DONORS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TELOMERE; TELOMERE SHORTENING; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME;

EID: 85032017028     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-209897     Document Type: Article

References (10)

1. Todd JL, Palmer SM. Bronchiolitis obliterans syndrome: The final frontier for lung transplantation. Chest 2011;140:502-8.
2. Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second official adult heart transplantation report-2015; focus theme: Early graft failure. J Heart Lung Transplant 2015;34:1244-54.
3. Jäger K, Walter M. Therapeutic targeting of telomerase. Genes (Basel) 2016;7:E39.
4. Domaski L, Koda K, Kwiatkowska E, et al. Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: A prospective cohort study. BMC Nephrol 2015;16:23.
5. Gadalla SM, Wang T, Haagenson M, et al. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia. JAMA 2015;313:594-602.
6. Tokman S, Singer JP, Devine MS, et al. Clinical outcomes of lung transplant recipients with telomerase mutations. J Heart Lung Transplant 2015;34:1318-24.
7. Courtwright AM, Fried S, Villalba JA, et al. Association of donor and recipient telomere length with clinical outcomes following lung transplantation. PLoS ONE 2016;11:e0162409.
8. Alder JK, Chen JJ, Lancaster L, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 2008;105:13051-6.
9. Naikawadi RP, Disayabutr S, Mallavia B, et al. Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis. JCI Insight 2016;1:e86704.
10. De Vlaminck I, Martin L, Kertesz M, et al. Noninvasive monitoring of infection and rejection after lung transplantation. Proc Natl Acad Sci USA 2015;112:13336-41.